Buying its own future output: the company is spending now to own more of the value it already helps create
The model's full reasoning — Q4 2022 call → NOWe need to determine if management describes the company currently moving itself further up or down its own value chain, taking ownership or direct control of a step that someone else used to perform, and that this move is already being executed and changing what the company earns or can do. Let's analyze the transcript. The company is Impinj, a RAIN RFID company. They make endpoint ICs (chips) and systems (readers, gateways). They also have inlay partners. They mention wafer supply, post-processing, etc. Key points: They talk about "expanded 300 millimeter post-processing to volume production." They mention "teething issues as we ramp our expanded 300 millimeter post-processing." This suggests they are bringing post-processing in-house? Or expanding their own post-processing? Let's see. In the transcript: "we can and will ramp shipments into that strong demand. That said, our shipment volumes will remain constrained at least into second-half 2023 to wafer-delivery timing and teething issues as we ramp our expanded 300 millimeter post-processing to volume production." So they are expanding their own post-processing capacity. Is that taking over a step that someone else used to perform? Typically, semiconductor companies outsource wafer fabrication and sometimes packaging/test. Post-processing might refer to something like thinning, dicing, or maybe they are doing more of the manufacturing steps themselves. But is this a move up or down the value chain? They are internalizing a step that was previously outsourced? The transcript doesn't explicitly say they are taking over from a third party. It says "expanded 300 millimeter post-processing" - so they are expanding their own capability. But was it previously outsourced? Possibly they had some post-processing done by partners, and now they are bringing it in-house? The transcript doesn't explicitly state that. It says "our inlay partners layered on additional bookings as our wafer visibility improved" - so inlay partners are separate. They are talking about wafer supply and post-processing. Also, they mention "we anticipate growing endpoint IC shipment volumes" and "we expect to be hand-to-mouth on finished endpoint ICs at least until second-half 2023" due to wafer-delivery timing and teething issues. So they are ramping up their own post-processing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| KMDA | Kamada Ltd. | Q2 2023 | 2023-08-16 | B+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| PRPO | Precipio, Inc. | Q3 2018 | 2018-11-19 | D |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
| GES | Guess?, Inc. | Q1 2017 | 2016-05-25 | F |
FLEX · Q1 2018 → YESThe question is about whether Flex Ltd is currently moving itself further up or down its own value chain by taking ownership or control of a step that someone else used to perform. YES The transcript shows Flex is actively internalizing a previously external step in the shoe manufacturing value chain by taking ownership of automation, process redesign, and end-to-end production for Nike. Management describes this as an ongoing, real-time execution: “we’re vertically integrating technologies,” “rethinking all of the whole supply process we’re applying automation technologies,” “we’ve manufactured over 1 million pairs,” and “we took over the facility in September” for Bose, with the Nike factory transition “complete by October.” They explain the value capture: the company now keeps margin it previously paid away, controls quality, cost, supply, and timing previously constrained by a counterparty, and serves customers it could not reach through the old chain. While acknowledging the ramp is early (losses persist through Q2, breakeven expected by year-end), the move is already changing what Flex earns and can do, not merely planned or contemplated. This meets all three required elements.
XOM · Q2 2018 → YESThe question is about whether ExxonMobil is currently moving itself further up or down its own value chain by taking ownership or control of a step that someone else used to perform. YES The transcript shows ExxonMobil actively internalizing logistics and supply-chain steps that previously required external partners or intermediaries. Neil Chapman explicitly states they “will get engaged in the connectivity between the Permian and our Gulf Coast refining and chemical assets,” with equity participation in logistics, the Wink terminal acquisition (closed late 2017), 11 active completion crews, and a signed letter of intent for a 1 million bpd long-haul crude pipeline. These moves are already producing results: Gulf Coast refineries are “already processing our production levels and more, capturing the benefits of disadvantaged feed cost.
KMDA · Q2 2023 → YESThe question is about whether management describes the company currently moving itself further up or down its own value chain, taking ownership of a step that someone else used to perform, and that th...YES The transcript shows management describing the 2021 acquisition of the Beaumont plasma collection center as the company's entry into U.S. plasma collection, with the explicit goal of becoming a "fully integrated specialty plasma product company." They state they are "successfully expanding" capacity at the first center (already acquired and operational) and plan to open the second in Houston in early 2024. This is presented as an active, ongoing move to internalize plasma collection that previously depended on external suppliers.